Skip to content

Investigation of Desmoplastic Squamous Cell Carcinoma

Prospektive Therapie-Studie Zur Behandlung Des Desmoplastischen Plattenepithelkarzinoms

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02717936
Acronym
DesmoPEK
Enrollment
73
Registered
2016-03-24
Start date
2016-01-31
Completion date
2020-01-31
Last updated
2016-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Squamous Cell Carcinoma of the Skin

Keywords

squamous cell carcinoma, dermatosurgery, immunohistochemistry

Brief summary

Aim of the study is to verify wether it is possible to have a more sensitive diagnostic tool using pancytokeratin immunohistochemistry for desmoplastic squamous cell carcinoma compared to regular H&E staining. The investigators therefore plan to include 73 participants with a confirmed diagnosis of desmoplastic squamous cell carcinoma and do regular follow up.

Interventions

PROCEDUREImmunohistochemistry using Pancytokeratin Staining

Sponsors

University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* desmoplastic squamous cell carcinoma (SCC) of the skin

Exclusion criteria

* tumor recurrence * collision tumors * other skin malignancies * progeria * Rothmund-Thomson-Syndrome * lacking of the capacity for informed consent

Design outcomes

Primary

MeasureTime frame
Recurrence free survival of patients with desmoplastic squamous cell carcinoma (SCC) diagnosed with immunohistochemistry .4 years

Secondary

MeasureTime frame
Reduction of local recurrence with immunohistochemistry4 years
Histological pattern of tumour growth (continuous versus discontinuous)4 years
Dimension of the tumor spreading according to histological work-up (measured in mm)4 years
Presence of perineurial and perivascular tumor invasion according to histological work-up4 years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026